What procurement risks should hospital buyers price into Parenteral Nutrition Market contracts?

Single-source amino acid and lipid concentrate supply is the dominant exposure. Contracts should carry dual-sourcing clauses, allocation-priority language, and indexed price adjustment bands, since 2023 shortages moved concentrate pricing 22% within a quarter [2]. Read More

How do buyers evaluate outsourced compounding versus in-house preparation?

Compare fully loaded pharmacist and technician minutes per bag against outsourced unit price plus waste. Facilities with fewer than 40 admixtures daily rarely justify in-house automation [15]. Read More

Which certifications matter when qualifying Parenteral Nutrition Market suppliers?

Verify current GMP status with the relevant regulator, USP <797> or PIC/S compliance for compounding partners, and documented endotoxin and particulate testing regimes. Inspection history matters more than certificate age [24]. Read More

What integration challenges arise when adding connected infusion pumps?

Interoperability with the electronic health record drug library is the usual bottleneck. Budget six to nine months for formulary mapping and biomedical validation before clinical go-live [9]. Read More

How does the Parenteral Nutrition Market differ commercially from enteral supply?

Parenteral products are regulated as sterile injectables, carrying far higher manufacturing barriers and margins. Enteral products face lighter regulation and compete more closely with consumer nutrition economics [17]. Read More

Is home therapy financially attractive for provider organisations?

Only where professional services are separately reimbursed. Without that layer, providers absorb nursing and monitoring costs while losing inpatient revenue, which stalls programme scaling [6]. Read More

What emerging clinical uses could expand demand beyond current indications?

Perioperative optimisation in high-risk surgical candidates and structured support during intensive oncology regimens are the most credible expansions. Both remain evidence-limited but are under active trial [19]. Read More

Parenteral Nutrition Market (2026 - 2035)

ID: MRFR/HC/41726-HCR 111 Pages Rahul Gotadki Last Updated: September 17, 2026

Parenteral Nutrition Market Research Report: Size, Share, Trend Analysis By Product Type (Total Parenteral Nutrition, Partial Parenteral Nutrition, Intravenous Fat Emulsions, Amino Acid Solutions, Carbohydrates Solutions), By Route of Administration (Central Venous Catheter, Peripheral Venous Catheter, Implantable Port), By End Users (Hospitals, Homecare Settings, Ambulatory Surgical Centers, Nursing Facilities), By Component (Amino Acids, Dextrose, Lipids, Vitamins, Electrolytes) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Parenteral Nutrition Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)6.22%

2025 Market SizeUSD 9.06 Billion

2035 Market SizeUSD 16.56 Billion

Key Players

Baxter International

Fresenius Kabi

B. Braun Melsungen

Otsuka Holdings

ICU Medical

Sichuan Kelun Pharmaceutical

Trends

Demographic Load on Clinical Nutrition Services
Neonatal Protocols and Early Aggressive Nutrition
Reimbursement Migration Toward the Home

Opportunities

Standardized Formats in Tier-2 Emerging Market Hospitals
Lipid Emulsion Reformulation Around Omega-3 Evidence
Connected Pumps and Therapy Data as a Revenue Line

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology |
4. 1.4 Market Summary
2 Key Report Takeaways |
1. 2.1 By Nutrition Type |
2. 2.2 By Patient Type and End-User |
3. 2.3 By Region
3 Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2024) |
2. 3.2 Base Year Analysis (2025) |
3. 3.3 Current & Forecast Market Size (2026–2035) |
4. 3.4 Year-over-Year Growth Analysis
4 Market Drivers Analysis |
1. 4.1 Demographic Load on Clinical Nutrition Services |
2. 4.2 Neonatal Protocols and Early Aggressive Nutrition |
3. 4.3 Reimbursement Migration Toward the Home |
4. 4.4 Format Standardisation and Pharmacy Economics
5 Market Restraints Analysis |
1. 5.1 Infection Risk as a Structural Ceiling |
2. 5.2 Input Concentration and Price Volatility |
3. 5.3 The Enteral-First Reflex
6 Market Opportunity Analysis |
1. 6.1 Standardized Formats in Tier-2 Emerging Market Hospitals |
2. 6.2 Lipid Emulsion Reformulation Around Omega-3 Evidence |
3. 6.3 Connected Pumps and Therapy Data as a Revenue Line |
4. 6.4 Intestinal Failure Centres of Excellence |
5. 6.5 Compounding Automation for Mid-Sized Systems |
6. 6.6 Industry Value Chain Analysis |
7. 6.7 Porter's Five Forces Analysis
7 Regional Analysis |
1. 7.1 North America | |
  1. 7.1.1 United States | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 United Kingdom | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Algorithmic Prescribing and Closed-Loop Monitoring |
2. 8.2 Platform Economics in Outsourced Compounding |
3. 8.3 Supply Sovereignty and Dual Sourcing |
4. 8.4 Sustainability Pressure on Packaging and Cold Chain
9 Market Segmentation Analysis |
1. 9.1 By Nutrition Type | |
  1. 9.1.1 Carbohydrates | |
  2. 9.1.2 Parenteral Lipid Emulsion | |
  3. 9.1.3 Single Dose Amino Acid Solution | |
  4. 9.1.4 Multi-Dose Amino Acid Solution | |
  5. 9.1.5 Trace Elements | |
  6. 9.1.6 Vitamins & Minerals | |
  7. 9.1.7 Electrolytes | |
  8. 9.1.8 Others |
2. 9.2 By Patient Type | |
  1. 9.2.1 Neonates | |
  2. 9.2.2 Pediatrics | |
  3. 9.2.3 Adults | |
  4. 9.2.4 Geriatrics |
3. 9.3 By End-User | |
  1. 9.3.1 Hospitals | |
  2. 9.3.2 Clinics | |
  3. 9.3.3 Homecare | |
  4. 9.3.4 Others
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Baxter International | |
  2. 10.3.2 Fresenius Kabi | |
  3. 10.3.3 B. Braun Melsungen | |
  4. 10.3.4 Otsuka Holdings | |
  5. 10.3.5 ICU Medical | |
  6. 10.3.6 Sichuan Kelun Pharmaceutical | |
  7. 10.3.7 Grifols | |
  8. 10.3.8 Terumo Corporation | |
  9. 10.3.9 Nestlé Health Science | |
  10. 10.3.10 Pfizer (Hospira) | |
  11. 10.3.11 CSL Vifor
11 Recent Developments & News
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Valuation Currency & Assumptions |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Parenteral Nutrition Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Parenteral Nutrition Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis – Global Parenteral Nutrition Market, 2026–2035 |
TABLE 4 Restraint Impact Analysis – Global Parenteral Nutrition Market, 2026–2035 |
TABLE 5 Global Parenteral Nutrition Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Parenteral Nutrition Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Parenteral Nutrition Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Parenteral Nutrition Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Parenteral Nutrition Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Parenteral Nutrition Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Parenteral Nutrition Market Size, by Nutrition Type, 2021–2035 (USD Billion) |
TABLE 12 Global Parenteral Nutrition Market Size, by Patient Type, 2021–2035 (USD Billion) |
TABLE 13 Global Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 14 North America Parenteral Nutrition Market Size, by Nutrition Type, 2021–2035 (USD Billion) |
TABLE 15 North America Parenteral Nutrition Market Size, by Patient Type, 2021–2035 (USD Billion) |
TABLE 16 North America Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 17 Europe Parenteral Nutrition Market Size, by Nutrition Type, 2021–2035 (USD Billion) |
TABLE 18 Europe Parenteral Nutrition Market Size, by Patient Type, 2021–2035 (USD Billion) |
TABLE 19 Europe Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 20 Asia-Pacific Parenteral Nutrition Market Size, by Nutrition Type, 2021–2035 (USD Billion) |
TABLE 21 Asia-Pacific Parenteral Nutrition Market Size, by Patient Type, 2021–2035 (USD Billion) |
TABLE 22 Asia-Pacific Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 23 South America Parenteral Nutrition Market Size, by Nutrition Type, 2021–2035 (USD Billion) |
TABLE 24 South America Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 25 Middle East & Africa Parenteral Nutrition Market Size, by Nutrition Type, 2021–2035 (USD Billion) |
TABLE 26 Middle East & Africa Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 27 United States Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 28 China Parenteral Nutrition Market Size, by Nutrition Type, 2021–2035 (USD Billion) |
TABLE 29 India Parenteral Nutrition Market Size, by Patient Type, 2021–2035 (USD Billion) |
TABLE 30 Germany Parenteral Nutrition Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 31 Competitive Benchmarking Matrix – Global Parenteral Nutrition Market, 2026 |
TABLE 32 Company Profiles – Key Players, Global Parenteral Nutrition Market |
TABLE 33 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 34 Report Scope & Methodology Summary |
TABLE 35 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Global Parenteral Nutrition Market – Market Dynamics Overview (Drivers, Restraints, Opportunities) |
FIGURE 2 Industry Value Chain Analysis – Raw Materials to Patient Delivery |
FIGURE 3 Porter's Five Forces Analysis – Global Parenteral Nutrition Market |
FIGURE 4 Global Market Size Trend Line, 2021–2035 (USD Billion) |
FIGURE 5 Year-over-Year Growth Rate Curve, 2022–2035 (%) |
FIGURE 6 Market Share by Nutrition Type, 2025 vs 2035 (%) |
FIGURE 7 Market Share by Patient Type, 2025 vs 2035 (%) |
FIGURE 8 Market Share by End-User, 2025 vs 2035 (%) |
FIGURE 9 Regional Revenue Share Distribution, 2025 (%) |
FIGURE 10 Regional CAGR Comparison, 2026–2035 (%) |
FIGURE 11 North America Country-Level Revenue Split, 2025 (%) |
FIGURE 12 Europe Country-Level Revenue Split, 2025 (%) |
FIGURE 13 Asia-Pacific Country-Level Revenue Split, 2025 (%) |
FIGURE 14 Competitive Landscape – Estimated Revenue Share Bands, 2026 (%) |
FIGURE 15 Competitive Positioning Matrix – Portfolio Breadth vs Geographic Reach |
FIGURE 16 Hospital vs Homecare Delivery Mix Shift, 2025–2035 (%) |
FIGURE 17 Driver Impact Weighting Chart, 2026–2035 |
FIGURE 18 Restraint Impact Weighting Chart, 2026–2035

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Nutrition Type	Carbohydrates; Parenteral Lipid Emulsion; Single Dose Amino Acid Solution; Multi-Dose Amino Acid Solution; Trace Elements; Vitamins & Minerals; Others	Single Dose Amino Acid Solution	Parenteral Lipid Emulsion
By Patient Type	Neonates; Pediatrics; Adults; Geriatrics	Adults	Neonates
By End-User	Hospitals; Clinics; Homecare; Others	Hospitals	Homecare
By Region	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Nutrition Type

Sub-Segment	Key Trend
Carbohydrates	Dextrose concentration standardisation reduces compounding variability across formularies.
Parenteral Lipid Emulsion	Fish-oil and olive-oil blends displace pure soybean-oil formulations on outcome evidence.
Single Dose Amino Acid Solution	Contamination-risk avoidance sustains premium over multi-dose presentations.
Multi-Dose Amino Acid Solution	Retained in high-throughput tertiary pharmacies where batch economics dominate
Trace Elements	Long-duration therapy guidelines mandate routine supplementation, lifting attach rates.
Vitamins & Minerals	Single-vial multivitamin formats simplify additive workflow and cut spiking errors.
Others	Specialty electrolyte concentrates grow with renal- and hepatic-adjusted regimens.

Product mix, not volume, drives most of the value growth in this dimension. Amino acid solutions hold the largest revenue pool, while lipid emulsions deliver the steepest growth as reformulated blends command materially higher pricing per gram of delivered lipid.

By Patient Type

Sub-Segment	Key Trend
Neonates	Early aggressive amino acid protocols raise per-patient consumption in Level III units.
Pediatrics	Congenital GI conditions and paediatric oncology sustain specialised formulation demand.
Adults	Oncology and gastrointestinal surgery remain the dominant initiation pathways.
Geriatrics	Post-surgical malnutrition and frailty extend average therapy duration.

Adults anchor absolute demand, but the neonatal cohort sets the growth pace because protocol adoption raises consumption independently of birth rates. Geriatric demand rises steadily as populations age across Japan, Italy, and Germany.

By End-User

Sub-Segment	Key Trend
Hospitals	Multi-chamber bag conversion redirects pharmacy labour toward clinical verification.
Clinics	Day-oncology and ambulatory infusion centres absorb short-duration regimens.
Homecare	Portable pumps and reimbursed professional services enable long-duration therapy outside acute wards.
Others	Long-term care and rehabilitation settings adopt simplified premixed formats.

Hospitals will retain majority share throughout the forecast, yet the structural story is migration outward. Homecare grows fastest wherever payers fund the professional services layer alongside the product itself.

By Region

Sub-Segment	Key Trend
North America	Mature home infusion infrastructure plus onshoring of amino acid inputs
Europe	Guideline harmonisation and EU-preference procurement reshape tender scoring.
Asia-Pacific	Volume-based procurement compresses pricing while access expansion lifts volumes.
South America	Licensed third-party compounding centres consolidate SUS oncology demand.
Middle East & Africa	Gulf hospital construction and Egyptian insurance rollout widen the base.

Regional divergence follows reimbursement design more than disease prevalence. Systems paying for home delivery compound faster; systems paying only for inpatient episodes grow at hospital-admission rates.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”